Investors

The dedicated section to find out all about Voluntis’ financial news.


Voluntis team during a meeting

Company overview

Voluntis at a glance

Learn more


Documents

Investors presentation, financial reports, document information…

Learn more


Voluntis investors meeting

Events

Upcoming events and General Meetings documents.

Learn more


Voluntis IPO at Euronext

Stock information

ID card, shareholder structure and analyst coverage.

Learn more

Voluntis latest news

Finance 2 September 2021

Voluntis announces the completion of the acquisition by Aptar of a majority stake in Voluntis at a price of €8.70 per share

Product 7 June 2021

Voluntis receives FDA 510(k) clearance for a new version of Insulia supporting an expanded range of basal insulins